Rustoleum

Closed
715 Park North Blvd Ste 100
Clarkston, GA 30021

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company based in Conshohocken, Pennsylvania, dedicated to developing innovative therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with a high unmet medical need. Their lead clinical candidate, resmetirom, is currently undergoing studies for the treatment of patients with NASH and significant liver fibrosis.

With a focus on improving care for patients with NASH, Madrigal Pharmaceuticals is committed to advancing novel treatments for this challenging liver disease. Despite the lack of FDA-approved options for NASH, the company's efforts aim to address the significant clinical impact of the condition and provide hope for those affected by it.

Generated from the website

Own this business?
See a problem?

You might also like